Abvc Biopharma Stock Price on November 26, 2024
ABVC Stock | USD 0.53 0.02 3.92% |
Below is the normalized historical share price chart for ABVC Biopharma extending back to November 10, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ABVC Biopharma stands at 0.53, as last reported on the 30th of November, with the highest price reaching 0.55 and the lowest price hitting 0.52 during the day.
If you're considering investing in ABVC Stock, it is important to understand the factors that can impact its price. ABVC Biopharma secures Sharpe Ratio (or Efficiency) of -0.0313, which signifies that the company had a -0.0313% return per unit of volatility over the last 3 months. ABVC Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ABVC Biopharma's Market Risk Adjusted Performance of 0.3747, variance of 33.36, and Mean Deviation of 3.76 to double-check the risk estimate we provide.
At present, ABVC Biopharma's Common Stock Shares Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 15.2 M, whereas Common Stock is forecasted to decline to 7,543. . As of November 30, 2024, Price To Sales Ratio is expected to decline to 31.34. In addition to that, Price Earnings Ratio is expected to decline to -0.5. ABVC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of October 2017 | 200 Day MA 0.8615 | 50 Day MA 0.5912 | Beta 0.816 |
ABVC |
Sharpe Ratio = -0.0313
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ABVC |
Estimated Market Risk
5.9 actual daily | 52 52% of assets are less volatile |
Expected Return
-0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ABVC Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABVC Biopharma by adding ABVC Biopharma to a well-diversified portfolio.
Price Book 0.7474 | Enterprise Value Ebitda (1.90) | Price Sales 47.579 | Shares Float 9.1 M | Wall Street Target Price 2.02 |
ABVC Biopharma Main Headline on 26th of November 2024
Filed transaction by ABVC Biopharma Director, 10 Percent Owner . Grant, award or other acquisition pursuant to Rule 16b-3
ABVC Biopharma Valuation on November 26, 2024
It is possible to determine the worth of ABVC Biopharma on a given historical date. On November 26, 2024 ABVC was worth 0.52 at the beginning of the trading date compared to the closed value of 0.51. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ABVC Biopharma stock. Still, in general, we apply an absolute valuation method to find ABVC Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ABVC Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ABVC Biopharma's related companies.
Open | High | Low | Close | Volume | |
0.55 | 0.55 | 0.52 | 0.52 | 108,539 | |
11/26/2024 | 0.52 | 0.54 | 0.50 | 0.51 | 133,928 |
0.50 | 0.54 | 0.50 | 0.51 | 53,020 |
Backtest ABVC Biopharma | | | ABVC Biopharma History | | | ABVC Biopharma Valuation | Previous | Next |
ABVC Biopharma Trading Date Momentum on November 26, 2024
On November 27 2024 ABVC Biopharma was traded for 0.51 at the closing time. The top price for the day was 0.54 and the lowest listed price was 0.50 . The trading volume for the day was 53 K. The trading history from November 27, 2024 did not affect price variability. The overall trading delta against the current closing price is 5.88% . |
ABVC Biopharma Fundamentals Correlations and Trends
By evaluating ABVC Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ABVC Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ABVC financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ABVC Biopharma Stock history
ABVC Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ABVC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ABVC Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ABVC Biopharma stock prices may prove useful in developing a viable investing in ABVC Biopharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 4.3 M | 4.6 M | |
Net Loss | -14.8 M | -14 M |
ABVC Biopharma Stock Technical Analysis
ABVC Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ABVC Biopharma Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
ABVC Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ABVC Biopharma November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how ABVC Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ABVC Biopharma shares will generate the highest return on investment. By undertsting and applying ABVC Biopharma stock market strength indicators, traders can identify ABVC Biopharma entry and exit signals to maximize returns
ABVC Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ABVC Biopharma's price direction in advance. Along with the technical and fundamental analysis of ABVC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ABVC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.16) | |||
Total Risk Alpha | (1.22) | |||
Treynor Ratio | 0.3647 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |